Smaller niche qPharmetra operates with a lean team (11-50 employees) and focuses on specialized pharmacometric services, presenting targeted upsell opportunities to expand their project scope within pharmacometrics, clinical pharmacology, and regulatory document preparation.

Regulatory focus The company provides regulatory document preparation (Modules 271, 272, 264), suggesting a potential sales angle with CROs and pharma/biotech firms needing strategic support for regulatory submissions and Health Authority interactions.

Service breadth With offerings spanning NCA, population PK/PD modeling and simulation, clinical trial simulations, and decision analysis, there are cross-sell opportunities to existing and prospective clients seeking end-to-end pharmacometric solutions.

Tech stack Utilizes modern tools (OpenAI, Azure, WordPress, Gravity Forms), indicating openness to partnerships around data analytics automation, cloud-based workflows, and client portal enhancements to improve efficiency and scale.

Financials + growth Revenue in the $1M-$10M range and a growth profile implied by funding activity, suggesting mid-market collaboration potential with larger CROs or pharma groups for larger, multi-year engagements.